Improving AAV Gene Therapy Safety Analysis: Multiplex LAM-PCR Provide New Insights Into AAV Vector Integration

被引：0
|
作者：
Gil-Farina, Irene [1 ]
Kaeppel, Christine [1 ]
Wilkening, Stefan [1 ]
Lopez-Franco, Esperanza [2 ]
Paneda, Maria Astrid [3 ]
Prieto, Jesus [4 ]
Spronck, Lisa [5 ]
von Kalle, Christof [1 ]
Petry, Harald [5 ]
Gonzalez-Aseguinolaza, Gloria [2 ]
Schmidt, Manfred [1 ]
机构：
[1] NCT DKFZ, Translat Oncol, Heidelberg, Germany
[2] CIMA, Gene Therapy & Hepatol, Pamplona, Spain
[3] DIGNA Biotech SL, Madrid, Spain
[4] Univ Hosp Navarra, Pamplona, Spain
[5] uniQure, Amsterdam, Netherlands
来源：
MOLECULAR THERAPY | 2015年 / 23卷
关键词：
D O I：
10.1016/S1525-0016(16)34273-3
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
664
引用
收藏
页码：S264 / S264
页数：1
相关论文
共 41 条
  • [21] Safety and Toxicology of Ocular Gene Therapy with Recombinant AAV Vector rAAV.hCNGA3 in Nonhuman Primates (vol 30, pg 50, 2019)
    Peters, Tobias
    Seitz, Immanuel Philipp
    Michalakis, Stylianos
    Biel, Martin
    Wilhelm, Barbara
    Reichel, Felix
    Ochakovski, Guy Alexander
    Zrenner, Eberhart
    Ueffing, Marius
    Korbmacher, Birgit
    Korte, Sven
    Bartz-Schmidt, Karl Ulrich
    Fischer, Manuel Dominik
    HUMAN GENE THERAPY, 2020, 31 (23-24) : 1312 - 1312
  • [22] Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy
    A-M Lompré
    L Hadri
    E Merlet
    Z Keuylian
    N Mougenot
    I Karakikes
    J Chen
    F Atassi
    A Marchand
    R Blaise
    I Limon
    S W J McPhee
    R J Samulski
    R J Hajjar
    L Lipskaia
    Gene Therapy, 2013, 20 : 901 - 912
  • [23] Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy
    Lompre, A-M
    Hadri, L.
    Merlet, E.
    Keuylian, Z.
    Mougenot, N.
    Karakikes, I.
    Chen, J.
    Atassi, F.
    Marchand, A.
    Blaise, R.
    Limon, I.
    McPhee, S. W. J.
    Samulski, R. J.
    Hajjar, R. J.
    Lipskaia, L.
    GENE THERAPY, 2013, 20 (09) : 901 - 912
  • [24] Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery
    Castle, Michael J.
    Baltanas, Fernando C.
    Kovacs, Imre
    Nagahara, Alan H.
    Barba, David
    Tuszynski, Mark H.
    HUMAN GENE THERAPY, 2020, 31 (7-8) : 415 - 422
  • [25] Pronounced and persistent hepatotropism with high tolerability of an AAV-FVIII gene therapy vector (BAY 2599023) for treatment of haemophilia A: A nonclinical safety and biodistribution study in mice
    Reetz, F.
    Flagella, K.
    Ivens, I. A.
    Stoica, L.
    Wadsworth, S.
    HAEMOPHILIA, 2019, 25 : 165 - 165
  • [26] Safety and Biodistribution Study of IntraArticular Delivered ICM-203, an AAV Gene Therapy Vector for Osteoarthritis, in Normal Rodents and Osteoarthritis-Induced Beagle Dogs
    Park, Minsun
    Yoo, Ji-Ye
    Kim, Yeonjin
    Choi, Minji
    Yoo, Myung Seok
    Ryu, Heui-Young
    Kim, Daegun
    Yum, Yong Na
    Kim, Dae-Won
    MOLECULAR THERAPY, 2023, 31 (04) : 173 - 174
  • [27] Validity and safety preclinical in vivo study of gene therapy for hypophosphatasia using ARU-2801 (AAV8 vector expressing TNALP-D10)
    Shadid, M.
    Gaukel, E.
    Zhao, D.
    Tanaka, Y.
    Miyake, N.
    Matsumoto, T.
    Miyake, K.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A167 - A167
  • [28] Safety and Biodistribution Assessment in Non-Human Primates (NHPs) of a miniMECP2 AAV9 Vector for Gene-Replacement Therapy of Rett Syndrome
    Prasad, Suyash
    Flora, Govinder
    Newman, Mary
    Gray, Steven J.
    Sinnett, Sarah E.
    Sadhu, Chanchal
    MOLECULAR THERAPY, 2022, 30 (04) : 303 - 303
  • [29] Assessment of Safety and Biodistribution of a miniMECP2 AAV9 Vector for Gene-replacement Therapy of Rett Syndrome in Non-human Primates (NHPs)
    Prasad, S.
    Flora, G.
    Newman, M.
    Gray, S. J.
    Sinnett, S.
    Sadhu, C.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A89 - A90
  • [30] Long-Term AAV-Mediated Factor VIII Expression in Nine Hemophilia A Dogs: A 10 Year Follow-up Analysis on Durability, Safety and Vector Integration
    Nguyen, Giang N.
    Everett, John K.
    Raymond, Hayley
    Kafle, Samita
    Merricks, Elizabeth P.
    Kazazian, Haig H.
    Nichols, Timothy C.
    Bushman, Frederic D.
    Sabatino, Denise E.
    BLOOD, 2019, 134
12345